CONFIDENT-HFpEF: A Machine Learning-Based Risk Stratification for Mortality and Hospitalization Using Multimodal Real-World Data

RECOMMENDED

Further Publications

Blood Pressure Variability and Risk of Cardiovascular Events and Mortality in Real-World Clinical Settings

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

J Am Heart Assoc

Li HL, Lin HJ, Muo CH, Lu CY, Kuo CC, Chen PC

doi: 10.1161/JAHA.124.037658

Cardiovascular Risk and Diseases

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Diabetes Obes Metab

Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J

doi: 10.1111/dom.70214

Hypertension

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Drugs Real World Outcomes

Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH

doi: 10.1007/s40801-025-00536-4

Heart Failure

Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12

J Am Coll Cardiol

El-Sabawi BR, Al-Garadi MA, Steitz BD, Perkins AM, McCoy AB, Sengstack DG, Greevy RA Jr, Burnell EH, Schlendorf KH, Lindenfeld J, Stevenson LW, Gupta DK, Spertus JA, Collins SP, Matheny ME, Bachmann JM

doi: 10.1016/j.jacc.2025.03.545

Cardiovascular Risk and Diseases

Cardiorenal risk stratification in high-risk type 2 diabetes using a simple clinical score: findings from the ELIXA trial

Front Endocrinol (Lausanne)

Jiang W, Wang J, Li J, Li Y, Zhang Y, Xu J, Zhang J, Gao Z, Cheng J, Yang J, Chang B

doi: 10.3389/fendo.2026.1768816

Atrial FibrillationFurther Publications

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

Circ Arrhythm Electrophysiol

Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A, Diouf Y, Jacon P, Fauchier L

doi: 10.1161/CIRCEP.125.014101

Atrial FibrillationFurther Publications

Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real-World Data

J Am Heart Assoc

Fath AR, Aglan A, Naidu SS, Mader MJ, Chilton RJ, Elgendy IY, Maron MS, Rowin EJ

doi: 10.1161/JAHA.125.045994

Heart Failure

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Fail

Schjødt I, Valentin JB, Johnsen SP, Mols RE, Egstrup K, Løgstrup BB

doi: 10.1002/ehf2.15320

Heart, Artery and Coronary DiseasesTherapy and Intervention

Patient risk evaluation for transcatheter aortic valve replacement (PRE-TAVR) - identification of real-time predictors of short- and long-term mortality

Clin Res Cardiol

Kreutz J, Lauten P, Chatzis G, Nabrotzki M, Patsalis N, Syntila S, Lapp H, Schieffer B, Markus B

doi: 10.1007/s00392-025-02704-6

Related content